NCT03478592

Brief Summary

The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies (ART) center of Toulouse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
423

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 27, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2021

Completed
Last Updated

October 28, 2021

Status Verified

October 1, 2021

Enrollment Period

3 years

First QC Date

March 15, 2018

Last Update Submit

October 27, 2021

Conditions

Keywords

Slow-freezingVitrificationAutomated systemEmbryosImplantation

Outcome Measures

Primary Outcomes (1)

  • Implantation rate of frozen/thawed embryos

    The number of implantation embryo with cardiac activity in reference technique and in vitrification technic

    1 month

Secondary Outcomes (3)

  • Percentage of intact blastomeres after thawing

    1 month

  • Implantation rate of transferred embryos.

    1 month

  • Live birth rates

    9 months after the implantation

Study Arms (2)

reference technique slow freezing

EXPERIMENTAL

In reference technique slow freezing arm, embryon will be frozen with the conventional slow freezing procedure with the Freezal device apply a slow decreasing in temperature with moderate cryoprotector concentration

Other: reference technique

vitrification technique

EXPERIMENTAL

In vitrification technique arm, embryon will be frozen with automated vitrification system

Other: vitrification technique

Interventions

Slow-freezing procedure is the reference technique, actually use at the Toulouse hospital, to cryopreserve embryos. Embryon are frozen with a slow freezing.

reference technique slow freezing

Vitrification is the new technique to freeze embryons. In this study, the GAVI system will be use for for embryos automatically vitrification

vitrification technique

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Couple whose age is \> 18 years and who are included in a IVF procedure with the possibility to cryopreserve embryos according to criteria applied at the hospital of Toulouse
  • Signed informed consent by both partners in a couple
  • Affiliation to a social security scheme for both partners of the couple

You may not qualify if:

  • Couples who does not meet current requirements described by the bioethics law for accession to the ART procedure
  • One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
  • Couple included in another interventional study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital university of Toulouse

Toulouse, 31059, France

Location

Study Officials

  • Roger Léandri, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2018

First Posted

March 27, 2018

Study Start

January 19, 2018

Primary Completion

February 3, 2021

Study Completion

February 3, 2021

Last Updated

October 28, 2021

Record last verified: 2021-10

Locations